↓ Skip to main content

Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate

Overview of attention for article published in BMC Pharmacology and Toxicology, January 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate
Published in
BMC Pharmacology and Toxicology, January 2013
DOI 10.1186/2050-6511-14-7
Pubmed ID
Authors

Mohamed A Ibrahim, Diana V Do, Yasir J Sepah, Syed M Shah, Elizabeth Van Anden, Gulnar Hafiz, J Kevin Donahue, Richard Rivers, Jai Balkissoon, James T Handa, Peter A Campochiaro, Quan Dong Nguyen

Abstract

This study was designed to assess the safety, tolerability, and efficacy of intravenous infusion of CA4P in patients with neovascular age-related macular degeneration (AMD).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 5%
United Kingdom 1 2%
Unknown 57 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 15%
Student > Bachelor 7 11%
Student > Ph. D. Student 6 10%
Student > Doctoral Student 6 10%
Professor > Associate Professor 5 8%
Other 12 20%
Unknown 16 26%
Readers by discipline Count As %
Medicine and Dentistry 14 23%
Agricultural and Biological Sciences 7 11%
Chemistry 5 8%
Nursing and Health Professions 4 7%
Biochemistry, Genetics and Molecular Biology 4 7%
Other 13 21%
Unknown 14 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2013.
All research outputs
#18,326,065
of 22,693,205 outputs
Outputs from BMC Pharmacology and Toxicology
#310
of 438 outputs
Outputs of similar age
#220,626
of 283,921 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#11
of 15 outputs
Altmetric has tracked 22,693,205 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 438 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,921 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.